Top 5 Japanese Pharma Company

To validate commercial potential and support product development, a large pharmaceutical company required an independent assessment of its internal early stage compound in development for oral mucositis, including a patient based model of the opportunity in each of these markets, with a primary focus on the Japan, followed by EU5 and US.

Our Solution

• GlobalData Consulting leveraged internal cancer epidemiology and conducted in-depth secondary research utilizing both public and proprietary data sources.
• In addition, GlobalData conducted in-depth KOL interviews in each geography to gather insights on current and future trends, unmet needs, requirements for new product development, potential TPPs testing.

Outcome

GlobalData Consulting delivered an in-depth market landscaping (epidemiology, patient management, unmet needs, trends) as well as development recommendations and product forecast, enabling the company to optimize their R&D efforts and manage commercial expectations.